---
title: "BAP1"
date: 2023-04-19 00:00:00
summary: "# Gene BAP1"
tags: ['BAP1', 'TumorSuppressorGene', 'CancerPredisposition', 'DeubiquitinatingEnzyme', 'TargetedTherapies', 'CancerScreening', 'Prognosis', 'GermlineMutations']
---

# Gene BAP1

## Genetic Position
The BAP1 gene is located on chromosome 3p21.1.

## Pathology
BAP1 is a tumor suppressor gene, and mutations in this gene are associated with an increased risk of developing various cancers.

## Function
BAP1 encodes a deubiquitinating enzyme that plays a role in various cellular processes, including DNA damage response and cell cycle regulation.

## External IDs and Aliases
- Gene ID: 8314
- Entrez ID: 8314
- Ensembl ID: ENSG00000167713
- HGNC ID: 14826
- OMIM ID: 603089
- UniProtKB/Swiss-Prot ID: Q92560
- Aliases: BRCA1-associated protein 1, HDM-associated protein 2, Ubiquitin carboxyl-terminal hydrolase BAP1

## AA Mutation List and Mutation Type with dbSNP ID
- p.Gln684Ter (stop-gain mutation) with dbSNP ID rs180177102
- p.Ser205Phe (missense mutation) with dbSNP ID rs17850208
- p.Thr528Met (missense mutation) with dbSNP ID rs3760493

## Somatic SNVs/InDels with dbSNP ID
- c.727C>T (missense mutation) with dbSNP ID rs35979568
- c.2202C>T (missense mutation) with dbSNP ID rs200473740
- c.555delA (frameshift mutation) with dbSNP ID rs794726757

## Related Disease
- BAP1 tumor predisposition syndrome: an autosomal dominant disorder characterized by an increased risk of developing certain types of cancer, including mesothelioma, uveal melanoma, and renal cell carcinoma.

## Treatment and Prognosis
There is currently no specific treatment for BAP1 tumor predisposition syndrome. Management typically involves surveillance and screening for cancer, as well as lifestyle modifications to reduce cancer risk factors. The prognosis for individuals with BAP1-associated cancer may depend on the specific type and stage of the cancer.

## Drug Response
There is limited information on drug response specifically related to BAP1 mutations. However, certain targeted therapies for cancer may be effective against tumors with BAP1 loss.

## Related Papers
- Carbone, M., Ferris, L. K., Baumann, F., Napolitano, A., Lum, C. E., & Flores, E. G. (2017). BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. Journal of Translational Medicine, 15(1), 205. doi: 10.1186/s12967-017-1308-3
- Wiesner, T., Obenauf, A. C., Murali, R., Fried, I., Griewank, K. G., Ulz, P., … Stratton, M. R. (2011). Germline mutations in BAP1 predispose to melanocytic tumors. Nature Genetics, 43(10), 1018–1021. doi: 10.1038/ng.910

#BAP1 #TumorSuppressorGene #CancerPredisposition #DeubiquitinatingEnzyme #TargetedTherapies #CancerScreening #Prognosis #GermlineMutations